BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma
Clinical trial NCT07008053 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07008053
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2027-07-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.